Free Trial
NASDAQ:PRTG

Portage Biotech (PRTG) Stock Price, News & Analysis

Portage Biotech logo
$9.30 -0.67 (-6.72%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$8.87 -0.43 (-4.58%)
As of 08/8/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Portage Biotech Stock (NASDAQ:PRTG)

Key Stats

Today's Range
$8.08
$10.06
50-Day Range
$5.29
$9.97
52-Week Range
$2.10
$23.01
Volume
121,342 shs
Average Volume
38,969 shs
Market Capitalization
$9.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Portage Biotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

PRTG MarketRank™: 

Portage Biotech scored higher than 7% of companies evaluated by MarketBeat, and ranked 903rd out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Portage Biotech.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Portage Biotech is -0.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Portage Biotech is -0.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Portage Biotech's valuation and earnings.
  • Percentage of Shares Shorted

    9.12% of the float of Portage Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Portage Biotech has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Portage Biotech has recently decreased by 45.57%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Portage Biotech does not currently pay a dividend.

  • Dividend Growth

    Portage Biotech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.12% of the float of Portage Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Portage Biotech has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Portage Biotech has recently decreased by 45.57%, indicating that investor sentiment is improving significantly.
  • Search Interest

    Only 1 people have searched for PRTG on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Portage Biotech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    42.07% of the stock of Portage Biotech is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 13.36% of the stock of Portage Biotech is held by institutions.

  • Read more about Portage Biotech's insider trading history.
Receive PRTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter.

PRTG Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
PRTG Portage Biotech Inc. - Seeking Alpha
Portage Biotech Regains Nasdaq Compliance
Portage Biotech Inc. (PRTG) Cash Flow - Yahoo Finance
See More Headlines

PRTG Stock Analysis - Frequently Asked Questions

Portage Biotech's stock was trading at $5.17 at the beginning of 2025. Since then, PRTG stock has increased by 79.9% and is now trading at $9.30.

Portage Biotech Inc. (NASDAQ:PRTG) announced its quarterly earnings data on Tuesday, November, 26th. The company reported ($1.26) EPS for the quarter.

Portage Biotech's stock reverse split on the morning of Thursday, August 15th 2024.The 1-20 reverse split was announced on Tuesday, August 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, August 14th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of PRTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Portage Biotech investors own include Meta Platforms (META), Alimera Sciences (ALIM), Angion Biomedica (ANGN), AirMedia Group (ANTE), Broadcom (AVGO), Barnwell Industries (BRN) and Crescent Biopharma (CBIO).

Company Calendar

Last Earnings
11/26/2024
Today
8/08/2025
Next Earnings (Estimated)
8/26/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PRTG
CIK
1095435
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.02
Quick Ratio
2.02

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.79) per share
Price / Book
-11.77

Miscellaneous

Outstanding Shares
1,050,000
Free Float
608,000
Market Cap
$9.77 million
Optionable
Optionable
Beta
0.24
10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:PRTG) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners